Vanguard Group Inc Precigen, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,759,360 shares of PGEN stock, worth $5.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,759,360
Previous 6,768,234
0.13%
Holding current value
$5.68 Million
Previous $9.81 Million
8.83%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PGEN
# of Institutions
144Shares Held
145MCall Options Held
292KPut Options Held
53.8K-
Third Security, LLC83.5MShares$70.1 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD18.2MShares$15.3 Million1.57% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$8.61 Million0.0% of portfolio
-
Iridian Asset Management LLC3.78MShares$3.17 Million0.8% of portfolio
-
Geode Capital Management, LLC Boston, MA3.1MShares$2.6 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $175M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...